U.S. Stem Cell Therapy Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on US Stem Cell Therapy Market 

5.1. COVID-19 Landscape: US Stem Cell Therapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. US Stem Cell Therapy Market, By Product

8.1. US Stem Cell Therapy Market, by Product, 2024-2033

8.1.1. Adult Stem Cells (ASCs)

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Human Embryonic Stem Cells (HESCs)

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Induced Pluripotent Stem Cells (iPSCs)

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Very Small Embryonic Like Stem Cells

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. US Stem Cell Therapy Market, By Therapy Type

9.1. US Stem Cell Therapy Market, by Therapy Type, 2024-2033

9.1.1. Autologous

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Allogenic

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. US Stem Cell Therapy Market, By Application 

10.1. US Stem Cell Therapy Market, by Application, 2024-2033

10.1.1. Regenerative Medicine

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Drug Discovery and Development

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. US Stem Cell Therapy Market, By Technology

11.1. US Stem Cell Therapy Market, by Technology, 2024-2033

11.1.1. Cell Acquisition

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Cell Production

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Cryopreservation

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Expansion and Sub-Culture

11.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 12. US Stem Cell Therapy Market, By End User

12.1. US Stem Cell Therapy Market, by End User, 2024-2033

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. Research Institutes

12.1.2.1. Market Revenue and Forecast (2021-2033)

12.1.3. Surgical Institutes

12.1.3.1. Market Revenue and Forecast (2021-2033)

12.1.4. Orders

12.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 13. US Stem Cell Therapy Market and Trend Forecast

13.1. U.S.

13.1.1. Market Revenue and Forecast, by Product (2021-2033)

13.1.2. Market Revenue and Forecast, by Therapy Type (2021-2033)

13.1.3. Market Revenue and Forecast, by Application (2021-2033)

13.1.4. Market Revenue and Forecast, by Technology (2021-2033)

13.1.5. Market Revenue and Forecast, by End User (2021-2033)

Chapter 14. Company Profiles

14.1. Caladrius

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. CELGENE CORPORATION

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Opexa Therapeutics, Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Seneca Biopharmaceuticals, Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms